200 related articles for article (PubMed ID: 21969911)
81. Interaction of synaptotagmin with voltage gated calcium channels: a role in Lambert-Eaton myasthenic syndrome?
David P; Martin-Moutot N; Leveque C; el Far O; Takahashi M; Seagar MJ
Neuromuscul Disord; 1993; 3(5-6):451-4. PubMed ID: 8186692
[TBL] [Abstract][Full Text] [Related]
82. [LEMS: Clinical Significance of Pathogenic Autoantibodies].
Motomura M; Irioka T
Brain Nerve; 2023 Jul; 75(7):837-845. PubMed ID: 37431074
[TBL] [Abstract][Full Text] [Related]
83. Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.
Flink MT; Atchison WD
J Physiol; 2002 Sep; 543(Pt 2):567-76. PubMed ID: 12205190
[TBL] [Abstract][Full Text] [Related]
84. Lambert-eaton myasthenic syndrome: a harbinger to transitional cell carcinoma of the urinary bladder.
Katirji B
J Clin Neuromuscul Dis; 2000 Mar; 1(3):134-6. PubMed ID: 19078572
[TBL] [Abstract][Full Text] [Related]
85. Long-term survival in paraneoplastic Lambert-Eaton myasthenic syndrome.
Maddison P; Gozzard P; Grainge MJ; Lang B
Neurology; 2017 Apr; 88(14):1334-1339. PubMed ID: 28251917
[TBL] [Abstract][Full Text] [Related]
86. An autoimmune channelopathy associated with cancer: Lambert-Eaton myasthenic syndrome.
Takamori M
Intern Med; 1999 Feb; 38(2):86-96. PubMed ID: 10225662
[TBL] [Abstract][Full Text] [Related]
87. Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome.
Maddison P; Gozzard P; Sadalage G; Ambrose PA; Chapman CJ; Murray A; Thomsen S; Berretta A; Lang B
J Neuroimmunol; 2020 Mar; 340():577149. PubMed ID: 31951874
[TBL] [Abstract][Full Text] [Related]
88. Paraneoplastic Lambert-Eaton myasthenic syndrome: a diagnostic challenge.
Viveiros L; Martins SR; Pires SX; Neves J
BMJ Case Rep; 2023 Jan; 16(1):. PubMed ID: 36707096
[TBL] [Abstract][Full Text] [Related]
89. [Lambert-Eaton myasthenia syndrome--review with case report].
Engler F
Fortschr Neurol Psychiatr; 1990 Dec; 58(12):447-54. PubMed ID: 1964928
[TBL] [Abstract][Full Text] [Related]
90. Immunocytochemical characteristics of small cell lung carcinoma associated with the Lambert-Eaton myasthenic syndrome.
Morris CS; Esiri MM; Marx A; Newsom-Davis J
Am J Pathol; 1992 Apr; 140(4):839-45. PubMed ID: 1314026
[TBL] [Abstract][Full Text] [Related]
91. A rare case of concomitant Lambert-Eaton myasthenic syndrome and syndrome of inappropriate antidiuretic hormone secretion in a patient with small cell lung carcinoma.
Oda Y; Tsubouchi H; Ishii N; Kitamura A; Moriyama E; Mitsutome E; Sakai K; Shiomi K; Yanagi S; Miyazaki T
Respir Med Case Rep; 2023; 46():101930. PubMed ID: 37920363
[TBL] [Abstract][Full Text] [Related]
92. Transient subacute cerebellar ataxia in a patient with Lambert-Eaton myasthenic syndrome after intracranial aneurysm surgery.
Nakamura M; Yabe I; Sato K; Nakano F; Yaguchi H; Tsuji S; Shiraishi H; Yoneda M; Tanaka K; Motomura M; Sasaki H
Clin Neurol Neurosurg; 2008 May; 110(5):480-3. PubMed ID: 18295972
[TBL] [Abstract][Full Text] [Related]
93. Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.
Titulaer MJ; Maddison P; Sont JK; Wirtz PW; Hilton-Jones D; Klooster R; Willcox N; Potman M; Sillevis Smitt PA; Kuks JB; Roep BO; Vincent A; van der Maarel SM; van Dijk JG; Lang B; Verschuuren JJ
J Clin Oncol; 2011 Mar; 29(7):902-8. PubMed ID: 21245427
[TBL] [Abstract][Full Text] [Related]
94. Lambert-Eaton myasthenic syndrome in a young girl.
Moor SE; Gardin T
BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35228217
[TBL] [Abstract][Full Text] [Related]
95. Spontaneous regression of small cell lung cancer associated with Lambert-Eaton Myasthenic Syndrome: Case report.
Otani M; Nishimori M; Iwasa H; Iwamura M; Izumi T; Nakaji K; Nitta N; Miyatake K; Yoshimatsu R; Yamanishi T; Matsumoto T; Osaki Y; Wada N; Toi M; Yamamoto M; Nakatani Y; Kubota T; Yamagami T
Radiol Case Rep; 2023 Nov; 18(11):4036-4041. PubMed ID: 37680668
[TBL] [Abstract][Full Text] [Related]
96. Presynaptic Disorders: Lambert-Eaton Myasthenic Syndrome and Botulism.
Gable KL; Massey JM
Semin Neurol; 2015 Aug; 35(4):340-6. PubMed ID: 26502758
[TBL] [Abstract][Full Text] [Related]
97. Lambert-Eaton myasthenic syndrome: clinical diagnosis, immune-mediated mechanisms, and update on therapies.
Sanders DB
Ann Neurol; 1995 May; 37 Suppl 1():S63-73. PubMed ID: 8968218
[TBL] [Abstract][Full Text] [Related]
98. The Lambert-Eaton myasthenic syndrome 1988-2008: a clinical picture in 97 patients.
Titulaer MJ; Wirtz PW; Kuks JB; Schelhaas HJ; van der Kooi AJ; Faber CG; van der Pol WL; de Visser M; Sillevis Smitt PA; Verschuuren JJ
J Neuroimmunol; 2008 Sep; 201-202():153-8. PubMed ID: 18644631
[TBL] [Abstract][Full Text] [Related]
99. P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system.
Voltz R; Carpentier AF; Rosenfeld MR; Posner JB; Dalmau J
Muscle Nerve; 1999 Jan; 22(1):119-22. PubMed ID: 9883867
[TBL] [Abstract][Full Text] [Related]
100. Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome with SOX-1 Antibodies.
Wada S; Kamei M; Uehara N; Tsuzaki K; Hamano T
Intern Med; 2021 May; 60(10):1607-1610. PubMed ID: 33328403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
